The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.
Study Type
OBSERVATIONAL
Enrollment
5,360
No treatment given
Novo Nordisk Investigational Site
Plainsboro, New Jersey, United States
Novo Nordisk Investigational Site
São Paulo, Brazil
Novo Nordisk Investigational Site
Ontario, Canada
Novo Nordisk Investigational Site
Riyadh, Saudi Arabia
Overweight and obesity among patients with established CVD pooled across all countries
% of patients
Time frame: At the time of patient enrolment (Day 1/Visit 1)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novo Nordisk Investigational Site
Madrid, Spain